Experimental / Investigational Appeal Letter
Use this when the payer's medical policy classifies the service as experimental for this indication. It's the hardest to win and the highest-dollar — it lives or dies on the evidence you attach and, often, a peer-to-peer with the medical director.
What makes it win
- Attach peer-reviewed literature and specialty-society clinical guidelines supporting the service for this specific indication
- Cite FDA status (approval/clearance) and any part of the payer's own policy that does cover it
- Document why standard, covered alternatives were inappropriate or exhausted for this patient
- Request a peer-to-peer or medical-director review so the evidence is read by a clinician
The template
Replace the [BRACKETED] fields with your details. This is the manual version of the appeal Volari files for you automatically.
[PRACTICE LETTERHEAD] [DATE] [PAYER NAME] — Appeals Department / Medical Director [PAYER APPEALS ADDRESS] RE: Appeal of Experimental/Investigational Denial (CARC 55) Patient: [PATIENT NAME] Member ID: [MEMBER ID] Claim #: [CLAIM NUMBER] Date of Service: [DOS] CPT/HCPCS: [CPT CODE] Diagnosis: [ICD-10 CODE] To the Medical Director / Appeals Department: We are appealing the denial of [CPT CODE / SERVICE] as experimental or investigational. For this patient's indication, the service is supported by published evidence and established clinical use, and we request review of the enclosed literature. [PATIENT NAME] has [DIAGNOSIS / CLINICAL HISTORY]. Covered alternatives were [tried and failed / contraindicated]: [SPECIFICS WITH DATES]. The enclosed evidence supports this service for this indication: [CITE 1-3 PEER-REVIEWED STUDIES / SPECIALTY-SOCIETY GUIDELINE]. The service is [FDA-approved / FDA-cleared] for [INDICATION], and [PAYER]'s policy [POLICY NUMBER] covers it when [CRITERION], which this patient meets. Given the clinical stakes, we request a peer-to-peer review with the treating provider, [PROVIDER NAME], reachable at [PHONE]. Enclosed: office note dated [DOS], [cited literature], [FDA reference]. Sincerely, [PROVIDER NAME], [TITLE] [PRACTICE NAME] — NPI [NPI] TIN [TIN]
Common questions
When should I use an experimental / investigational appeal letter?
Use this when the payer's medical policy classifies the service as experimental for this indication. It's the hardest to win and the highest-dollar — it lives or dies on the evidence you attach and, often, a peer-to-peer with the medical director. It addresses: Experimental/investigational denials — CARC 55 (procedure/service deemed experimental or investigational).
What makes this appeal letter win?
Attach peer-reviewed literature and specialty-society clinical guidelines supporting the service for this specific indication; Cite FDA status (approval/clearance) and any part of the payer's own policy that does cover it; Document why standard, covered alternatives were inappropriate or exhausted for this patient; Request a peer-to-peer or medical-director review so the evidence is read by a clinician.
Don't write appeals one at a time.
Volari's AI agents build, file, and follow every appeal in your written-off pile — with the right argument and documentation. No risk, paid only on what we recover.